fda warning letters compounded semaglutide september 2025 Article: Brazilian Clinics and the False Equivalence of GLP-1 Drugs: ANVISA should follow Beyond the Headlines: FDA Warning

GLP-1 drugs are muting flavours and making food taste off Sweetness hits differently as brain responses shift Brands are boosting umami and texture to bring flavour back Smaller, protein-packed meals are leading the charge Growing scientific research and anecdotal evidence suggest that GLP-1 drugs may change how people experience taste

For people with type 2 diabetes, lower BMI thresholds may apply (30 kg/m) as outlined in NICE guidance

weight loss on semaglutide (Wegovy)

Even small changes in this order can significantly alter the peptides biological function

Dietary Strategies to Combat Insomnia on GLP-1 What and when you eat can have a profound impact on your sleep quality, especially when managing your diet on GLP-1 medications